Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Providence Therapeutics Announces World-First Personalized Pediatric mRNA Cancer Vaccine Trial
Friday, February 06, 2026Providence Therapeutics a Canadian clinicalstage mRNA biotechnology company is supporting a worldfirst clinical trial evaluating personalized mRNA cancer vaccines for children with advanced and treatmentresistant brain tumors
Invivoscribe® Launches LeukoStrat® KMT2A + MRD Assay to Advance High-Sensitivity Leukemia Testing in Clinical Trials and Patient Management Worldwide
Thursday, February 05, 2026Invivoscribe a leader in precision medicine and measurable residual disease MRD testing today announced the addition of the LeukoStrat KMTA MRD Assay and Software to its industryleading oncology portfolio
Cycle Pharmaceuticals Completes Acquisition of Applied Therapeutics
Wednesday, February 04, 2026Cycle Group Holdings Limited Cycle is delighted to announce it has completed the acquisition of NASDAQlisted Applied Therapeutics Inc NASDAQ APLT Applied a clinicalstage biopharmaceutical company
Frontage Laboratories Expands Early Phase Clinical Capabilities to Support Global Drug Development
Tuesday, February 03, 2026Frontage Laboratories Inc Frontage a global Contract Research Development and Manufacturing Organization CRDMO today announced the expansion of its early phase clinical research capabilities across the United States and China
Alvotech enters supply and commercialization agreements for Canada and Australia & New Zealand covering multiple biosimilar candidates
Tuesday, February 03, 2026Alvotech a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide today announced that it has entered into supply and commercialization agreements
Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Giuliana Rancic
Monday, February 02, 2026Sino Biological US Inc a global leader in recombinant proteins antibodies and CRO services will be featured on Inside Business Today hosted by Bill Rancic and Giuliana Rancic The segment titled Pioneering Life Sciences with HighQuality Bioreagents
Lilly selects Pennsylvania as home for its newest injectable medicine and device manufacturing facility
Saturday, January 31, 2026Eli Lilly and Company today announced plans to invest more than billion in a new manufacturing facility in the Lehigh Valley Pennsylvania The site will serve as Lillys newest injectable medicine and device manufacturing facility
Pharmaceutical Service Provider Vetter Pharma to Build New Manufacturing Site in Germany
Friday, January 30, 2026Vetter one of the worlds leading pharmaceutical service providers for the production of injectable drugs has confirmed its plans to build a stateoftheart production facility in the Saarland region of southwest Germany
Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development
Thursday, January 29, 2026Recent reports of Nipah virus NiV infections in West Bengal India have reignited global concern prompting public health authorities to prioritize research into this highmortality pathogen In response Sino Biological
Seamless Therapeutics Announces Global Research Collaboration with Lilly to Develop Programmable Recombinase-based Therapeutics for Hearing Loss
Thursday, January 29, 2026Seamless Therapeutics announced today that it has entered into a strategic global research collaboration and licensing agreement with Eli Lilly and Company Lilly to develop and commercialize programmable recombinasebased treatments
